TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
AKTS

Aktis Oncology, Inc.

Healthcare · Biotechnology

14.90$ +2.4% vs. previous close Closing price · As of: Nov 3, 2026

Statements

Income Statement

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Income Statement AKTS
Line item 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 0.02 0.00 0.06 0.05 0.05 0.28 0.00 0.78 0.04 0.12
– 0.00 0.01 0.05 0.04 0.07 0.36 – 0.87 0.81 –
– 0.02 -0.01 0.01 0.02 -0.02 -0.08 – -0.09 0.04 0.12
0.04 0.13 0.26 0.63 0.70 0.61 0.66 0.41 0.74 1.17 1.28
0.07 0.22 0.35 0.42 0.32 0.32 0.38 0.15 0.22 0.32 0.24
0.10 0.33 0.59 1.05 1.02 0.93 1.04 0.57 1.00 1.54 1.55
-0.11 -0.35 -0.59 -1.06 -1.00 -0.95 -1.12 -0.57 -1.00 -1.49 -1.42
– – – 0.02 0.10 0.14 0.00 – 0.07 0.08 –
-0.10 -0.40 -0.54 -1.04 -1.06 -1.07 -1.13 -0.51 -0.82 -1.26 -1.21
0.00 0.15 -0.10 0.01 0.06 – -0.03 – -0.07 0.00 –
-0.10 -0.40 -0.54 -1.04 -1.12 -1.21 -1.10 -0.51 -0.82 -1.26 -1.21
-0.05 -0.29 -0.62 -0.99 -0.91 -0.86 -0.98 -0.50 -0.79 -1.22 -1.17

Data as of: November 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?